The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) Expansion
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.
Also called NCT02070653
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 145 participants
- Sponsor
- Registry
-
NCT02070653
-
- Other papers using this trial's data
- The effect of ticagrelor on growth of small abdominal aortic aneurysms-a randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Sweden
- Registry status
- Completed
Technical summary
Registry record NCT02070653. Randomized; quadruple masking; primary purpose treatment. Start 2014-03 (actual); primary completion 2016-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) Expansion
- Acronym
- TicAAA
- Condition
- Abdominal Aortic Aneurysm
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Placebo
- Lead sponsor
- Uppsala University
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct02070653- Content hash
d90e5e68d9b1c5756b20566948d9e330cd7beafbd434c574f6298d02e436216c